Compare LRMR & BKKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LRMR | BKKT |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | United States |
| Employees | N/A | 559 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.0M | 246.3M |
| IPO Year | 2014 | N/A |
| Metric | LRMR | BKKT |
|---|---|---|
| Price | $5.16 | $9.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $16.29 | $13.00 |
| AVG Volume (30 Days) | ★ 6.3M | 1.2M |
| Earning Date | 04-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.61 | $6.81 |
| 52 Week High | $6.42 | $49.79 |
| Indicator | LRMR | BKKT |
|---|---|---|
| Relative Strength Index (RSI) | 63.82 | 38.90 |
| Support Level | $3.18 | $8.32 |
| Resistance Level | $5.37 | $11.25 |
| Average True Range (ATR) | 0.52 | 0.82 |
| MACD | 0.16 | 0.08 |
| Stochastic Oscillator | 66.13 | 13.95 |
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
Bakkt Inc is focused on building the backbone of next-generation financial infrastructure. The company provides financial technology solutions that support institutional participation in digital assets. Its offerings include infrastructure related to bitcoin, tokenization, stablecoin payments, and AI-enabled financial services. The company specializes in providing solutions designed to meet institutional requirements for security, scale, and regulatory compliance.